Imatinib (STI-571)-induced exfoliative dermatitis in a Saudi patient with deck chair sign.
Nusrat
N
Banka
Mahmoud
M
Aljurf
Issam
I
Hamadah
D000328:Adult; D001549:Benzamides; D001707:Biopsy, Needle; D003873:Dermatitis, Exfoliative / Q000139:chemically induced* / Q000473:pathology*; D005500:Follow-Up Studies; D006801:Humans; D000068877:Imatinib Mesylate; D007150:Immunohistochemistry; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D012529:Saudi Arabia; D012720:Severity of Illness Index
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate